Saroglitazar delivers positive Phase III results in rare liver disease PBC, U.S. filing planned 1 year ago JohnIn Pharma Industry UpdatesTop Stories
FDA approves Dupixent for chronic spontaneous urticaria in ages 12 and up 1 year ago JohnIn Breaking NewsFDA Approvals
FDA updates label for mavacamten after long-term studies show durable benefit in obstructive hypertrophic cardiomyopathy 1 year ago JohnIn BreakthroughsFDA ApprovalsResearch UpdatesTop Stories
Glycomine raises $115 million to push PMM2-CDG therapy into Phase 2b trial 1 year ago JohnIn InvestmentsPeopleVenture Capital
EU Unveils Public Clinical Trial Map to Boost Transparency and Patient Access 1 year ago JohnIn Featured AnalysisTop Stories
WHO Sparks Global Clinical Trials Momentum with Forum to Fast-Track Innovation 1 year ago JohnIn BreakthroughsIndustry ConferencesResearch Updates
Australia Boosts Brain Cancer Research with $5.9 Million Grant for Innovative Chair 1 year ago JohnIn Biopharma HighlightsPartnershipsPeople
UK Sets Stage for Smoother Clinical Trials with New Law Expected by Mid-April 1 year ago JohnIn BreakthroughsClinical TrialsPeople
Emerging biotechs increasingly driving drug approvals, reshaping industry dynamics 1 year ago JohnIn Biopharma HighlightsClinical Trials
Precision Psychiatry Breakthrough: BH-200 Antidepressant Combined with Genetic Testing Delivers Strong Response in Major Depression Trial 1 year ago JohnIn Research UpdatesTop Stories
FDA approves novel immunotherapy combo for colorectal cancer and clears new surgery technology 1 year ago JohnIn DealsFDA ApprovalsResearch Updates
MHRA unveils first-ever analysis of UK clinical trial applications, offering new roadmap for research growth 1 year ago JohnIn Breaking NewsClinical TrialsFeatured Analysis
New clinical trial regulations take effect in the UK as pandemic case rates remain steady 1 year ago JohnIn Industry ConferencesPharma Industry UpdatesTop Stories
UK Unveils Major Push to Accelerate Clinical Trials and Health Data Access 1 year ago JohnIn Biopharma HighlightsFeatured AnalysisIndustry ConferencesResearch Updates
PTC Therapeutics reports promising Phase 2 results in Huntington’s disease program 1 year ago JohnIn Clinical TrialsFeatured AnalysisResearch UpdatesTop Stories
